GovernanceCorporate Governance
Policy and Basic concept
In order to achieve sustainable growth and increase corporate value over the medium to long term, the Group has established a management system capable of making decisions and executing business in an appropriate and prompt manner in response to changes in the external environment. At the same time, to achieve management that is both fair and transparent, we have made corporate governance a priority.
In addition, in order to maintain and improve high ethical standards as a healthcare-related company, the Group companies as a whole will promote corporate activities under the shared corporate philosophy, in accordance with the standards of conduct and various internal regulations that should be taken toward various stakeholders.
The following is a diagram of the group's corporate governance.
Governance system
Guided by the above basic approach, we have advanced corporate governance reforms by increasing the number of outside directors, establishing a Nomination, Remuneration, and Other Governance Committee, and transitioning to a holding company structure. These initiatives have enabled us to enhance the Board of Directors’ supervisory functions while streamlining business execution. We have also worked to increase corporate value by building an agile execution framework that supports sustainable growth, complemented by effective oversight through thorough deliberations at board meetings.
To further strengthen our ability to respond to the rapidly changing external environment and achieve continued growth, we have decided to transition from a “company with audit & supervisory board” to a “company with audit & supervisory committee,” subject to approval at the 4th Annual General Meeting of Shareholders held on June 25, 2025. We also believe that having directors who are well-versed in both the medical and pharmaceutical industries—our group’s core business—and internal company matters, and who demonstrate strong ethics and provide oversight across all areas of the company, is the most effective way to ensure both efficiency and compliance in management. We have therefore adopted the audit & supervisory committee system, in which management is supervised by both outside directors and the audit and supervisory committee, as the most suitable structure for our company’s size and management style.
We expect our outside directors to provide valuable advice, sound judgment, and effective audit and supervisory functions from an independent perspective, drawing on their specialized knowledge and experience in fields such as corporate management, healthcare, global business, medical and pharmaceutical science, finance / accounting / tax practice, legal affairs / risk management, and sustainability / ESG.
Audit & Supervisory function
The Company has established the “Regulations of the Audit & Supervisory Committee,” “Code of Audit & Supervisory Committee Auditing and Supervising Standards,” and the “Regulations of Internal Audit,” and will strengthen its auditing and supervisory functions in cooperation with the Audit & Supervisory Committee, the Group Internal Inspection Office, and the accounting auditor.
The full-time Audit & Supervisory Committee member attends meetings of the Group Strategy Council, and other important meetings, inspects important approval documents, examines the state of operations and assets at the head office and major business locations. By reporting to the Audit & Supervisory Committee, the full-time Audit & Supervisory Committee member shares information and collaborates with the outside directors who also serve as Audit & Supervisory Committee. In addition, the full-time Audit & Supervisory Committee member maintains regular communication with the Representative Director through scheduled dialogues, and exchanges information with the directors and others at subsidiaries and receives reports on their business activities. The full-time Audit & Supervisory Committee member and the General Manager of the Group Internal Inspection Office exchange information as necessary regarding the establishment and operation of internal controls, operational audits, theme-based audits, and other matters, in accordance with the “Cabinet Office Ordinance on Systems to Ensure the Adequacy of Financial Calculation Documents and Other Information.” Internal audit reports prepared by the Group Internal Inspection Office are also provided to the full-time Audit & Supervisory Committee member, who then reports their contents to the Audit & Supervisory Committee.
The Audit & Supervisory Committee mainly conducts operational audits (audits of the “Maintenance and operation of a system to ensure appropriate business operations”), while the accounting auditor mainly conducts accounting audits, to improve audit efficiency. Both parties shall exchange relevant information and views to ensure that the audit is conducted thoroughly and without oversight. The Audit & Supervisory Committee also periodically receives explanations of the basic audit plan and audit summary reports to gain an understanding of the accounting auditor’s audit activities. In addition, the Audit Division (the Audit & Supervisory Committee, the Group Internal Inspection Office, and the accounting auditor) conducts audits of business sites to ensure the effectiveness of audits and to ensure that audits are conducted thoroughly throughout the Company.
Each department within the Audit Division gathers information and engages in dialogue with departments responsible for promoting internal control, assesses the development and implementation status of internal control systems, and, when necessary, reports to the Internal Control Committee to enhance internal control through opinions and recommendations.
Nomination, Remuneration and Other Governance Committee
The Company’s Nomination, Remuneration and Other Governance Committee performs the functions of both the Nomination Committee and the Remuneration Committee, and its members are composed of directors selected by resolution of the Board of Directors. The chairperson of the committee is elected by its members in accordance with internal regulations. Conversely, the lead independent outside director is elected by the outside directors. Members with a special interest in matters under deliberation are not permitted to participate in the resolution process.
Resolutions require both the presence of a majority of eligible members and the approval of a majority of those present.
The committee primarily deliberates on matters such as the appointment and dismissal of senior management, the selection and removal of the CEO, CEO succession planning, and the remuneration of senior management and executive officers. These discussions are conducted with consideration for diversity and a range of skills, including gender diversity. The outcomes of these deliberations are submitted to the Board of Directors. Regarding the appointment and dismissal of directors who are members of the Audit & Supervisory Committee, the committee deliberates in accordance with the “Code of Audit & Supervisory Committee Auditing and Supervising Standards” ensuring independence from management and maintaining impartiality. These matters are submitted to the Board of Directors as proposals for the General Meeting of Shareholders, following prior explanation to and approval by the Audit & Supervisory Committee.
Furthermore, Regulation of the Board of Directors stipulate that the Board of Directors shall fully respect the advice and recommendations received from the Committee.
Chairperson | External Director |
---|---|
Meeting held in fiscal 2024 | 7 |
Group Strategy Council
The Group Strategy Council deliberates on important matters to be submitted to the Board of Directors, discusses and decides the execution policy of matters resolved at the Board of Directors meetings, and analyzes business results and discusses the countermeasures.
Chairman | Representative Director and President (Group COO) |
---|---|
Meetings held in fiscal 2023 | 14 |
Group Sustainability Committee
The Group Sustainability Committee deliberates and decides on the Group's basic policy on sustainability, establishes and maintains a system for promoting sustainability, and assists Group companies in establishing and maintaining their own systems for promoting sustainability, and receives reports.
Chairman | Group Chief Sustainability Officer |
---|---|
Meetings held in fiscal 2023 | 4 |
Group Governance Council
The Group Governance Council, which is made up of four committees, meets to build, maintain, and improve the governance system of the entire Group. The council works to improve the sustainable growth and raise the corporate value of the overall Group in the medium and long term.
Chairman | Representative Director and Chairman (Group CEO) |
---|---|
Meetings held in fiscal 2023 | 1 |
Other committees
Group Investment Committee
The Group Investment Committee undertakes objective, rational, and careful deliberations when examining and making decisions regarding important investment projects and the annual investment budget.
Chairman | Representative Director and Chairman (Group CEO) |
---|---|
Meetings held in fiscal 2023 | 17 |
Group Risk Management Committee
To reinforce the management of various risks that the Company and Group companies face, the Group Risk Management Committee overseas risk management and manages and evaluates progress in managing risks and works to continually improve risk management.
Chairman | Group Chief General Affairs Officer |
---|---|
Meetings held in fiscal 2023 | 2 |
Group Compliance Committee
The Group Compliance Committee conducts education and enlightenment activities, etc., for officers and employees and strives to raise awareness of compliance throughout the Group.
Chairman | Group Chief Compliance Officer |
---|---|
Meetings held in fiscal 2023 | 9 |
Group Information Security Committee
The Group Information Security Committee shares information on information security, examines and deliberates on responses to issues, and works to smoothly manage information security.
Chairman | Group Chief Digital Transformation Officer |
---|---|
Meetings held in fiscal 2023 | 3 |
History of measures to strengthen governance
1995 | Established a system in which a majority of Audit & Supervisory Board Members (2 of 3) are external members |
---|---|
2008 | Established Compliance Committee and Internal Control Committee |
2012 | Appointed one Independent External Director |
2013 | Introduced stock option compensation for Directors |
2015 | Established CSR Committee (current Group Sustainability Committee) |
2015 | Formulated a basic policy on corporate governance |
2015 | Appointed female director as Independent External Director, creating a system of two independent external directors |
2015 | Established Information Security Committee |
2016 | Started to evaluate the effectiveness of the Board of Directors |
2017 | Established Risk Management Committee |
2019 | Established Nomination, Remuneration and Other Governance Committee |
2020 | Had independent external directors account for one-third of directors |
2021 | Transitioned to holding company (to strengthen group governance) |
2021 | Joined Listed Company Board Member’s Governance Forum and strengthened information sharing with and training for Directors and Audit & Supervisory Board Members |
2023 | Have independent external directors account for one-half of directors |
2025 | Transitioned to Company with Audit & Supervisory Committee |
* Items before transitioning to holding company in 2021 are for Sawai Pharmaceutical